Connect Sign In
GenomOncology announced that ARUP has chosen to extend its use of the GenomOncology (GO) Precision Oncology API Suite by integrating the GO Clinical Trial and Therapy Matching APIs into its workflows.
By the time ARUP’s Molecular Genetics COVID-19 Rapid Response Lab closed due to decreased demand, nearly 100 of the 120 employees hired to work in the lab had been placed in new positions at ARUP.
ARUP Blood Services and University of Utah Health join Intermountain Healthcare and the American Red Cross asking Utahns to donate blood.
The FDA recently approved a new precision therapy developed by Blueprint Medicines for adults with advanced systemic mastocytosis, a rare and potentially fatal hematologic malignancy.
Adam Barker, PhD, has been appointed as ARUP’s chief scientific officer, a role in which he will lead the newly formed New Technologies Group.
ARUP Laboratories today bid farewell to CEO Sherrie L. Perkins, MD, PhD, who retired after 31 years with the company and the University of Utah Department of Pathology.
Rapid antigen testing has been used widely during the COVID-19 pandemic to determine infection status in settings such as schools or workplaces, but its role has changed as the pandemic has evolved.
ARUP announced that it has received the 2021 Supplier Legacy Award from Premier Inc., a leading healthcare improvement company.
ARUP Laboratories, one of the nation’s largest reference laboratories, held a ribbon cutting ceremony to officially open its new four-story, 220,000-square-foot laboratory facility in Salt Lake City.
ARUP Laboratories has renewed its agreement to provide laboratory testing free of charge to Salt Lake City’s Fourth Street Clinic, a provider of healthcare to homeless men,
ARUP Laboratories has taken another step toward wise environmental stewardship with the opening of a new state-of-the-art bike storage facility that offers heightened securi
